Pantoprazole is a proton pump inhibitor (PPI) used to reduce stomach acid production. It’s commonly prescribed for conditions like gastroesophageal reflux disease (GERD), heartburn, and ulcers. Azurity Pharmaceuticals now offers FIRST®-Pantoprazole 4 mg/mL in a convenient compounding kit, providing a flexible option for patients requiring a liquid suspension.
This compounding kit contains pantoprazole sodium USP powder and a specially formulated diluent blend. When reconstituted with purified water, the kit yields a 4 mg/mL pantoprazole suspension. This format is particularly beneficial for patients who have difficulty swallowing pills, such as children or the elderly. The FIRST®-Mint Flavored Suspension Compounding Kit is available in a 300 mL size and is available by prescription only.
Pharmacists play a crucial role in ensuring the proper preparation and administration of compounded medications. Accurate measurement and mixing are essential to achieve the correct dosage. Patients should be counseled on the appropriate storage and handling of the reconstituted suspension.
Common side effects of pantoprazole can include headache, diarrhea, and abdominal pain. More serious, though less common, side effects may include low magnesium levels and an increased risk of certain infections. Patients should be advised to consult their doctor if they experience any adverse effects.
This new compounding kit offers a valuable alternative for patients who require a liquid form of pantoprazole. It allows for precise dosing and convenient administration. It’s important for healthcare professionals to be aware of this option and to educate patients on its proper use.
For more detailed information, consult the package insert or visit www.firstkits.com/pantoprazole/.
References:
- FIRST-Pantoprazole [package insert]. Woburn, MA: Azurity Pharmaceuticals Inc; 2023.
